<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Neurol.</journal-id>
<journal-title>Frontiers in Neurology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Neurol.</abbrev-journal-title>
<issn pub-type="epub">1664-2295</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fneur.2024.1371375</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neurology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Frontier and hotspot evolution in cerebrotendinous xanthomatosis: a bibliometric analysis from 1993 to 2023</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name><surname>Luo</surname> <given-names>Fei</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="author-notes" rid="fn0025"><sup>&#x2020;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1820629/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name><surname>Ding</surname> <given-names>Yali</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="author-notes" rid="fn0025"><sup>&#x2020;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2525309/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name><surname>Zhang</surname> <given-names>Shanyun</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<xref ref-type="author-notes" rid="fn0025"><sup>&#x2020;</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Diao</surname> <given-names>Juanjuan</given-names></name>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1814166/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Yuan</surname> <given-names>Bin</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x002A;</sup></xref>
<xref ref-type="author-notes" rid="fn0002"><sup>&#x2021;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1880720/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Pediatrics, Affiliated Hospital of Nanjing University of Chinese Medicine</institution>, <addr-line>Nanjing</addr-line>, <country>China</country></aff>
<aff id="aff2"><sup>2</sup><institution>Department of Pediatrics, Nanjing Gaochun Traditional Chinese Medicine Hospital</institution>, <addr-line>Nanjing</addr-line>, <country>China</country></aff>
<aff id="aff3"><sup>3</sup><institution>Department of Pediatrics, Haining Hospital of Chinese Medicine</institution>, <addr-line>Haining</addr-line>, <country>China</country></aff>
<aff id="aff4"><sup>4</sup><institution>Department of Pediatrics, Affiliated Hospital of Shandong University of Traditional Chinese Medicine</institution>, <addr-line>Jinan</addr-line>, <country>China</country></aff>
<author-notes>
<fn fn-type="edited-by" id="fn0003">
<p>Edited by: Paulo Victor Sgobbi Souza, Federal University of S&#x00E3;o Paulo, Brazil</p>
</fn>
<fn fn-type="edited-by" id="fn0004">
<p>Reviewed by: Wladimir Bocca Vieira De Rezende Pinto, Federal University of S&#x00E3;o Paulo, Brazil</p>
<p>Kang Zou, First Affiliated Hospital of Gannan Medical University, China</p>
</fn>
<corresp id="c001">&#x002A;Correspondence: Bin Yuan, <email>yuanbin68358@163.com</email></corresp>
<fn fn-type="equal" id="fn0025">
<p><sup>&#x2020;</sup>These authors have contributed equally to this work and share first authorship</p>
</fn>
<fn fn-type="other" id="fn0002">
<p><sup>&#x2021;</sup>ORCID: Bin Yuan, <ext-link ext-link-type="uri" xlink:href="https://orcid.org/0000-0002-6071-8925">https://orcid.org/0000-0002-6071-8925</ext-link></p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>26</day>
<month>07</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>15</volume>
<elocation-id>1371375</elocation-id>
<history>
<date date-type="received">
<day>17</day>
<month>01</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>15</day>
<month>07</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2024 Luo, Ding, Zhang, Diao and Yuan.</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Luo, Ding, Zhang, Diao and Yuan</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec id="sec1">
<title>Background</title>
<p>Cerebrotendinous xanthomatosis (CTX) is an autosomal recessive disease associated with lipid metabolic disorders. Because of its clinical diversity and rarity, the diagnosis is often unclear. However, there is still a lack of reports on bibliometric analysis of CTX. The aim of this study was to assess the progress and research developments of CTX over the past three decades, identify emerging trends, and establish novel directions for future research.</p>
</sec>
<sec id="sec2">
<title>Methods</title>
<p>The eligible literature were screened from the Web of Science Core Collection (WoSCC) database. The annual publication, countries, institutions, authors, journals, keywords and references were visually analyzed by Microsoft Excel 2019, CiteSpace 6.2.R4, VOSviewer 1.6.18 and online bibliometrics website (<ext-link xlink:href="https://bibliometric.com/" ext-link-type="uri">https://bibliometric.com/</ext-link>).</p>
</sec>
<sec id="sec3">
<title>Results</title>
<p>A total of 561 publications from WoSCC were included in this study. The United States is the country with the largest number of publications, and Karolinska Institutet is the institution with the largest number of publications. Bj&#x00F6;rkhem I. ranks as the most published and cited author in the last three decades. Journal of Lipid Research is the most widely published and cited journal. The strongest burst of keywords is &#x201C;diagnosis.&#x201D;</p>
</sec>
<sec id="sec4">
<title>Conclusion</title>
<p>Unraveling the pathogenesis of CTX and improving its diagnosis and treatment continue to be critical challenges that require urgent attention. Future research endeavors will be centered on enhancing the efficiency and accuracy of early diagnosis and intervention.</p>
</sec>
</abstract>
<kwd-group>
<kwd>bibliometric analysis</kwd>
<kwd>cerebrotendinous xanthomatosis</kwd>
<kwd>CiteSpace</kwd>
<kwd>VOSviewer</kwd>
<kwd>Web of Science</kwd>
</kwd-group>
<counts>
<fig-count count="8"/>
<table-count count="5"/>
<equation-count count="0"/>
<ref-count count="42"/>
<page-count count="12"/>
<word-count count="5256"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Neurogenetics</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="sec5">
<label>1</label>
<title>Introduction</title>
<p>Cerebrotendinous xanthomatosis (CTX, OMIM 213700) is a rare autosomal recessive disorder first delineated in 1937 by Van Bogaert et al. (<xref ref-type="bibr" rid="ref1">1</xref>), who described two cousins exhibiting chronic progressive neurological symptoms, one with concurrent cataracts and tendon xanthomas, classified as a systemic cerebral cholesterol storage disease. CTX is precipitated by mutations in the sterol 27-hydroxylase (<italic>CYP27A1</italic>) gene, characterized by the accumulation of abnormal sterols and bile acid precursors in various tissues (<xref ref-type="bibr" rid="ref2">2</xref>, <xref ref-type="bibr" rid="ref3">3</xref>). Elevated cholestanol levels in CTX patients were first documented by Menkes et al. (<xref ref-type="bibr" rid="ref4">4</xref>) in 1968. In 1971, Salen (<xref ref-type="bibr" rid="ref5">5</xref>) subsequently elucidated diminished bile acid (predominantly CDCA) excretion in patients, contributing to cholesterol and cholestanol deposition in tendon xanthomas. The biochemical foundation of CTX, linked to sterol 27-hydroxylase deficiency, was definitively established by Oftebro et al. (<xref ref-type="bibr" rid="ref6">6</xref>) in 1981. The first report of pathogenic mutations in the <italic>CYP27A1</italic> gene by Cali et al. (<xref ref-type="bibr" rid="ref7">7</xref>) in 1991 advanced the understanding of the molecular genetics underpinning CTX. Reports indicate that the prevalence of CTX is highest among Asian populations, with rates ranging from 1 in 44,407 to 1 in 93,084. Conversely, the lowest prevalence is found among Finns, at a rate of 1 in 3,388,767. The prevalence among Europeans, Americans, and Africans/African-Americans is moderate, estimated to be between 1 in 70,795 and 1 in 233,597 (<xref ref-type="bibr" rid="ref8">8</xref>). It can be manifested as neonatal cholestatic jaundice (<xref ref-type="bibr" rid="ref9">9</xref>). Common symptoms of the condition encompass tendon xanthomas, osteoporosis, coronary heart disease, and a range of progressive neuropsychiatric issues. Neurological disruptions often include peripheral neuropathy, pyramidal signs like spastic paraparesis, cerebellar ataxia, cognitive difficulties, and various movement disorders. During childhood and adolescence, the predominant signs are typically bilateral juvenile cataracts, persistent diarrhea, and intellectual challenges (<xref ref-type="bibr" rid="ref10">10</xref>, <xref ref-type="bibr" rid="ref11">11</xref>). The diagnosis is challenging and often unclear due to the rarity of the disease and its various non-specific symptoms. Current diagnosis primarily relies on clinical presentation, biochemical assays, and confirmatory genetic analysis, with neuroimaging serving as an adjunctive diagnostic tool. Treatment predominantly involves bile acid replacement therapy, such as chenodeoxycholic acid (CDCA).</p>
<p>CiteSpace (<xref ref-type="bibr" rid="ref12">12</xref>) and VOSviewer (<xref ref-type="bibr" rid="ref13">13</xref>) are bibliometrics softwares, which can analyze the research trends and frontier hotspots in a certain field through the integration of keywords, authors, countries, institutions and references of related publications. Web of science is the most authoritative citation database with the largest number of disciplines in the world, and focuses on natural sciences (<xref ref-type="bibr" rid="ref14">14</xref>). Compared with Scopus, WOS, it is more accurate and periodic (<xref ref-type="bibr" rid="ref15">15</xref>). Compared with the lack of citation information in PubMed, the publication information of WOS is more comprehensive (<xref ref-type="bibr" rid="ref16">16</xref>, <xref ref-type="bibr" rid="ref17">17</xref>).</p>
<p>In this study, based on the Web of Science Core Collection (WoSCC) database, the literature related to CTX in the past 30&#x2009;years was statistically analyzed and visual map was drawn to clarify the research trend and frontier hotspots of CTX.</p>
</sec>
<sec sec-type="materials|methods" id="sec6">
<label>2</label>
<title>Materials and methods</title>
<sec id="sec7">
<label>2.1</label>
<title>Data selection</title>
<p>We searched CTX literature at Web of Science Core Collection (WoSCC) on December 31, 2023. The following search strategies were used: TS&#x2009;=&#x2009;(cerebrotendinous xanthomatosis) AND DT&#x2009;=&#x2009;(Article OR Review) AND language&#x2009;=&#x2009;(English) AND PY&#x2009;=&#x2009;(1993.01.01&#x2013;2023.12.31).</p>
<p>A total of 561 publications met the retrieval requirements, and the fully recorded and cited references of the literature are derived in plain text format. The flowchart of the literature search is depicted in <xref ref-type="fig" rid="fig1">Figure 1</xref>.</p>
<fig position="float" id="fig1">
<label>Figure 1</label>
<caption>
<p>Flowchart of literature search.</p>
</caption>
<graphic xlink:href="fneur-15-1371375-g001.tif"/>
</fig>
</sec>
<sec id="sec8">
<label>2.2</label>
<title>Data analysis</title>
<p>Key information such as title, author, country, institution, keyword, and the year of publication were extracted from articles that met the criteria. Microsoft Excel 2019, CiteSpace 6.2.R4, VOSviewer 1.6.18 and online bibliometrics website<xref ref-type="fn" rid="fn0001"><sup>1</sup></xref> were used to process the above data.</p>
</sec>
</sec>
<sec sec-type="results" id="sec9">
<label>3</label>
<title>Results</title>
<sec id="sec10">
<label>3.1</label>
<title>Trends in publication outputs</title>
<p><xref ref-type="fig" rid="fig2">Figure 2</xref> depicts the annual number of CTX-related publications. Over the past 30&#x2009;years, the cumulative yearly total shown an overall upward trend, despite significant fluctuations in the annual number of papers published each year. In order to understand the trend of CTX research, the polynomial function <italic>Y</italic> =&#x2009;0.2176<italic>X</italic><sup>2</sup> + 10.411<italic>X</italic> +&#x2009;18.889 (<italic>R</italic><sup>2</sup> =&#x2009;0.9962, <italic>X</italic> is the year, <italic>Y</italic> is the annual cumulative number of articles) was constructed. And 2021 is the peak year for publication, with 35 articles.</p>
<fig position="float" id="fig2">
<label>Figure 2</label>
<caption>
<p>Trend of publications in the field of CTX (1993&#x2013;2023).</p>
</caption>
<graphic xlink:href="fneur-15-1371375-g002.tif"/>
</fig>
</sec>
<sec id="sec11">
<label>3.2</label>
<title>Analysis of countries and institutions</title>
<p>A total of 49 countries and 221 institutions have participated in CTX research in the past 30&#x2009;years. <xref ref-type="table" rid="tab1">Table 1</xref> displays the top 10 countries ranked by both publications and centrality. Betweenness centrality assesses a node&#x2019;s significance in a network, where higher values indicate the node acts more frequently as a bridge in facilitating communication between other nodes (<xref ref-type="bibr" rid="ref18">18</xref>). Nodes with centrality value &#x003E;0.1 are deemed significant. Among the papers published in this research field, the United States made the greatest contribution, with 172 papers, far more than other countries. Japan, Italy, the Netherlands and Sweden ranked from 2 to 5. <xref ref-type="fig" rid="fig3">Figure 3</xref> represents the CTX national collaboration network analysis. <xref ref-type="fig" rid="fig3">Figure 3A</xref> illustrates the geographical distribution of CTX publications, with a primary focus in North America and Western Europe. <xref ref-type="fig" rid="fig3">Figure 3B</xref> examines the international collaborations between clusters, where the size of the nodes reflects the number of publications and the lines denote the intensity of collaboration. As shown in <xref ref-type="table" rid="tab1">Table 1</xref> and <xref ref-type="fig" rid="fig3">Figure 3B</xref>, the United States is the core of the CTX collaboration network.</p>
<table-wrap position="float" id="tab1">
<label>Table 1</label>
<caption>
<p>The top 10 most publication countries.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Rank</th>
<th align="left" valign="top">Countries</th>
<th align="center" valign="top">Publications</th>
<th align="center" valign="top">Centrality</th>
<th align="left" valign="top">Countries</th>
<th align="center" valign="top">Centrality</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="middle">1</td>
<td align="left" valign="bottom">USA</td>
<td align="center" valign="middle">172</td>
<td align="center" valign="middle">0.52</td>
<td align="left" valign="bottom">USA</td>
<td align="char" valign="middle" char=".">0.52</td>
</tr>
<tr>
<td align="left" valign="middle">2</td>
<td align="left" valign="bottom">Japan</td>
<td align="center" valign="middle">64</td>
<td align="center" valign="middle">0.16</td>
<td align="left" valign="bottom">Germany</td>
<td align="char" valign="middle" char=".">0.28</td>
</tr>
<tr>
<td align="left" valign="middle">3</td>
<td align="left" valign="bottom">Italy</td>
<td align="center" valign="middle">59</td>
<td align="center" valign="middle">0.08</td>
<td align="left" valign="bottom">UK</td>
<td align="char" valign="middle" char=".">0.23</td>
</tr>
<tr>
<td align="left" valign="middle">4</td>
<td align="left" valign="bottom">Netherlands</td>
<td align="center" valign="middle">51</td>
<td align="center" valign="middle">0.08</td>
<td align="left" valign="bottom">Spain</td>
<td align="char" valign="middle" char=".">0.17</td>
</tr>
<tr>
<td align="left" valign="middle">5</td>
<td align="left" valign="bottom">Sweden</td>
<td align="center" valign="middle">48</td>
<td align="center" valign="middle">0.06</td>
<td align="left" valign="bottom">Japan</td>
<td align="char" valign="middle" char=".">0.16</td>
</tr>
<tr>
<td align="left" valign="middle">6</td>
<td align="left" valign="bottom">China</td>
<td align="center" valign="middle">44</td>
<td align="center" valign="middle">0</td>
<td align="left" valign="bottom">Italy</td>
<td align="char" valign="middle" char=".">0.08</td>
</tr>
<tr>
<td align="left" valign="middle">7</td>
<td align="left" valign="bottom">Germany</td>
<td align="center" valign="middle">40</td>
<td align="center" valign="middle">0.28</td>
<td align="left" valign="bottom">Netherlands</td>
<td align="char" valign="middle" char=".">0.08</td>
</tr>
<tr>
<td align="left" valign="middle">8</td>
<td align="left" valign="bottom">UK</td>
<td align="center" valign="middle">35</td>
<td align="center" valign="middle">0.23</td>
<td align="left" valign="bottom">Greece</td>
<td align="char" valign="middle" char=".">0.08</td>
</tr>
<tr>
<td align="left" valign="middle">9</td>
<td align="left" valign="bottom">France</td>
<td align="center" valign="middle">31</td>
<td align="center" valign="middle">0.07</td>
<td align="left" valign="bottom">Russia</td>
<td align="char" valign="middle" char=".">0.08</td>
</tr>
<tr>
<td align="left" valign="middle">10</td>
<td align="left" valign="bottom">Israel</td>
<td align="center" valign="middle">27</td>
<td align="center" valign="middle">0.04</td>
<td align="left" valign="bottom">France</td>
<td align="char" valign="middle" char=".">0.07</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p>Based on CiteSpace LLR algorithm outcomes, the countries correspond to those of all authors.</p>
</table-wrap-foot>
</table-wrap>
<fig position="float" id="fig3">
<label>Figure 3</label>
<caption>
<p>Analysis of the countries. <bold>(A)</bold> World the cooperation intensity map. <bold>(B)</bold> A circle diagram that evaluates international collaboration between clusters. Nodes represent countries, with node size indicating the number of publications, and lines showing the strength of collaboration.</p>
</caption>
<graphic xlink:href="fneur-15-1371375-g003.tif"/>
</fig>
<p><xref ref-type="table" rid="tab2">Table 2</xref> lists the top 5 most publication and top five most centrality institutions. 2 of the top 5 institutions are from the United States, and Karolinska Institute has the largest number of publications, with a total of 35 related papers. <xref ref-type="fig" rid="fig4">Figure 4</xref> shows the institutional collaboration network, with purple circles highlighting entities with centrality values greater than 0.1, denoting their significance within the network. Oregon Health &#x0026; Science University is the most centrality institution, which has some influence in the field of CTX.</p>
<table-wrap position="float" id="tab2">
<label>Table 2</label>
<caption>
<p>The top 5 most publication institutions.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Rank</th>
<th align="left" valign="top">Institutions</th>
<th align="left" valign="top">Country</th>
<th align="center" valign="top">Publications</th>
<th align="left" valign="top">Institutions</th>
<th align="left" valign="top">Country</th>
<th align="center" valign="top">Centrality</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">1</td>
<td align="left" valign="top">Karolinska Institute</td>
<td align="left" valign="top">Sweden</td>
<td align="center" valign="top">35</td>
<td align="left" valign="top">Oregon Health &#x0026; Science University</td>
<td align="left" valign="top">USA</td>
<td align="char" valign="top" char=".">0.24</td>
</tr>
<tr>
<td align="left" valign="top">2</td>
<td align="left" valign="top">University of Siena</td>
<td align="left" valign="top">Italy</td>
<td align="center" valign="top">20</td>
<td align="left" valign="top">Helmholtz Association</td>
<td align="left" valign="top">Germany</td>
<td align="char" valign="top" char=".">0.20</td>
</tr>
<tr>
<td align="left" valign="top">3</td>
<td align="left" valign="top">Rutgers State University New Brunswick</td>
<td align="left" valign="top">USA</td>
<td align="center" valign="top">19</td>
<td align="left" valign="top">Hebrew University of Jerusalem</td>
<td align="left" valign="top">Israel</td>
<td align="char" valign="top" char=".">0.19</td>
</tr>
<tr>
<td align="left" valign="top">4</td>
<td align="left" valign="top">Rutgers State University Medical Center</td>
<td align="left" valign="top">USA</td>
<td align="center" valign="top">18</td>
<td align="left" valign="top">Karolinska Institute</td>
<td align="left" valign="top">Sweden</td>
<td align="char" valign="top" char=".">0.18</td>
</tr>
<tr>
<td align="left" valign="top">5</td>
<td align="left" valign="top">Radboud University Nijmegen</td>
<td align="left" valign="top">Netherlands</td>
<td align="center" valign="top">18</td>
<td align="left" valign="top">University of California System</td>
<td align="left" valign="top">USA</td>
<td align="char" valign="top" char=".">0.10</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p>Based on CiteSpace LLR algorithm outcomes, the institutions correspond to those of all authors.</p>
</table-wrap-foot>
</table-wrap>
<fig position="float" id="fig4">
<label>Figure 4</label>
<caption>
<p>CiteSpace network map of institutions. Nodes represent institutions, with node size indicating publication volume, purple circles denote centrality &#x003E;0.1, and lines signify the strength of collaboration.</p>
</caption>
<graphic xlink:href="fneur-15-1371375-g004.tif"/>
</fig>
</sec>
<sec id="sec12">
<label>3.3</label>
<title>Analysis of authors and cited-authors</title>
<p><xref ref-type="table" rid="tab3">Table 3</xref> lists the top 5 authors with the most CTX publications and the most cited in CTX literature over the past three decades, primarily from Europe and the United States. The &#x201C;co-citation analysis&#x201D; feature identifies instances where two authors are cited together by other publications. CiteSpace software limits this analysis to the co-citations of the first author and counts multiple citations within the same publication once. The resulting co-citation network map reveals the academic collaborations within a research domain. Bj&#x00F6;rkhem I. is the most prolific and cited author, with 23 publications and 254 citations. <xref ref-type="fig" rid="fig5">Figure 5</xref> generated by VOSviewer, illustrates the author collaboration network. <xref ref-type="fig" rid="fig5">Figures 5A</xref>,<xref ref-type="fig" rid="fig5">B</xref> display the collaboration between authors and cited authors, with various colors indicating different clusters of collaborative relationships. These authors are at the central of distinct clusters, and collaborate closely. The burst detection analysis reflects hotspots emerging in field research, and when combined with timelines, it can clearly show the change trend of keyword, which effectively help the researchers in understanding shifts of the research focus. Among the top 25 cited authors in CTX publications from 1993 to 2023, Nie S. K. emerged as the author with the strongest burst of citations, while Oftebro H. had the longest duration of citation burst (<xref ref-type="fig" rid="fig6">Figure 6</xref>).</p>
<table-wrap position="float" id="tab3">
<label>Table 3</label>
<caption>
<p>The top 5 most publication authors and cited authors.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Rank</th>
<th align="left" valign="top">Author</th>
<th align="center" valign="top">Publications</th>
<th align="left" valign="top">Country</th>
<th align="left" valign="top">Cited-author</th>
<th align="center" valign="top">Cited frequency</th>
<th align="left" valign="top">Country</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">1</td>
<td align="left" valign="top">Bj&#x00F6;rkhem I.</td>
<td align="center" valign="top">23</td>
<td align="left" valign="top">Sweden</td>
<td align="left" valign="top">Bj&#x00F6;rkhem I.</td>
<td align="center" valign="top">254</td>
<td align="left" valign="top">Sweden</td>
</tr>
<tr>
<td align="left" valign="top">2</td>
<td align="left" valign="top">Salen G.</td>
<td align="center" valign="top">18</td>
<td align="left" valign="top">USA</td>
<td align="left" valign="top">Berginer V. M.</td>
<td align="center" valign="top">223</td>
<td align="left" valign="top">Israel</td>
</tr>
<tr>
<td align="left" valign="top">3</td>
<td align="left" valign="top">Federico A.</td>
<td align="center" valign="top">15</td>
<td align="left" valign="top">Italy</td>
<td align="left" valign="top">Cali J. J.</td>
<td align="center" valign="top">209</td>
<td align="left" valign="top">USA</td>
</tr>
<tr>
<td align="left" valign="top">4</td>
<td align="left" valign="top">Dotti M. T.</td>
<td align="center" valign="top">12</td>
<td align="left" valign="top">Italy</td>
<td align="left" valign="top">Salen G.</td>
<td align="center" valign="top">188</td>
<td align="left" valign="top">USA</td>
</tr>
<tr>
<td align="left" valign="top">5</td>
<td align="left" valign="top">Batta A. K.</td>
<td align="center" valign="top">11</td>
<td align="left" valign="top">USA</td>
<td align="left" valign="top">Verrips A.</td>
<td align="center" valign="top">164</td>
<td align="left" valign="top">Netherlands</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p>Based on CiteSpace LLR algorithm outcomes, the authors represent all contributors to the publication. The table does not discriminate between productivity (number of papers published in filed) and citation numbers.</p>
</table-wrap-foot>
</table-wrap>
<fig position="float" id="fig5">
<label>Figure 5</label>
<caption>
<p><bold>(A)</bold> Visualization of authors. <bold>(B)</bold> Visualization of cited authors. Nodes symbolize authors, in <bold>A</bold>, node size reflects the number of publications, in <bold>B</bold>, node size indicates citation frequency; different colors denote distinct clusters of collaborative relationships, and lines represent the strength of collaboration.</p>
</caption>
<graphic xlink:href="fneur-15-1371375-g005.tif"/>
</fig>
<fig position="float" id="fig6">
<label>Figure 6</label>
<caption>
<p>The top 25 cited authors with the strongest citation bursts. Strength indicates the intensity of citation bursts, with red denoting the duration of burst emergence.</p>
</caption>
<graphic xlink:href="fneur-15-1371375-g006.tif"/>
</fig>
</sec>
<sec id="sec13">
<label>3.4</label>
<title>Analysis of journals and cited journals</title>
<p>The top 5 publications and the top 5 cited journals are shown in <xref ref-type="table" rid="tab4">Table 4</xref>. <xref ref-type="table" rid="tab4">Table 4</xref> shows that the top three prolific journals are Journal of Lipid Research, Journal of Inherited Metabolic Disease and Journal of the Neurological Sciences. In addition, Journal of Lipid Research is also the most frequently cited journal, followed by Journal of Biological Chemistry and Neurology. Journal of Lipid Research is the largest node in <xref ref-type="fig" rid="fig7">Figure 7</xref>. Combined with <xref ref-type="table" rid="tab4">Table 4</xref>, it can be seen that its academic authority in the field of CTX research is better than that of other journals.</p>
<table-wrap position="float" id="tab4">
<label>Table 4</label>
<caption>
<p>The top 5 most publication journals and cited journals.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Rank</th>
<th align="left" valign="top">Journal</th>
<th align="center" valign="top">Publications</th>
<th align="center" valign="top">JCR quartile</th>
<th align="left" valign="top">Cited journal</th>
<th align="center" valign="top">Citations</th>
<th align="center" valign="top">JCR quartile</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="middle">1</td>
<td align="left" valign="middle">Journal of Lipid Research</td>
<td align="center" valign="middle">43</td>
<td align="center" valign="middle">Q1</td>
<td align="left" valign="middle">Journal of Lipid Research</td>
<td align="center" valign="middle">1,670</td>
<td align="center" valign="middle">Q1</td>
</tr>
<tr>
<td align="left" valign="middle">2</td>
<td align="left" valign="middle">Journal of Inherited Metabolic Disease</td>
<td align="center" valign="middle">21</td>
<td align="center" valign="middle">Q2</td>
<td align="left" valign="middle">Journal of Biological Chemistry</td>
<td align="center" valign="middle">1,420</td>
<td align="center" valign="top">Q2</td>
</tr>
<tr>
<td align="left" valign="middle">3</td>
<td align="left" valign="middle">Journal of the Neurological Sciences</td>
<td align="center" valign="middle">12</td>
<td align="center" valign="middle">Q2</td>
<td align="left" valign="middle">Journal of Clinical Investigation</td>
<td align="center" valign="middle">756</td>
<td align="center" valign="top">Q1</td>
</tr>
<tr>
<td align="left" valign="middle">4</td>
<td align="left" valign="middle">Journal of Biological Chemistry</td>
<td align="center" valign="middle">11</td>
<td align="center" valign="middle">Q1</td>
<td align="left" valign="middle">Neurology</td>
<td align="center" valign="middle">645</td>
<td align="center" valign="top">Q1</td>
</tr>
<tr>
<td align="left" valign="middle">5</td>
<td align="left" valign="middle">Journal of Neurology</td>
<td align="center" valign="middle">10</td>
<td align="center" valign="middle">Q1</td>
<td align="left" valign="middle">Journal of Inherited Metabolic Disease</td>
<td align="center" valign="middle">624</td>
<td align="center" valign="top">Q2</td>
</tr>
</tbody>
</table>
</table-wrap>
<fig position="float" id="fig7">
<label>Figure 7</label>
<caption>
<p>Visualization of cited journals. Nodes represent journals, with node size indicating citation frequency.</p>
</caption>
<graphic xlink:href="fneur-15-1371375-g007.tif"/>
</fig>
</sec>
<sec id="sec14">
<label>3.5</label>
<title>Analysis of keywords</title>
<p>Keywords can reflect the hot spots and cutting-edge trends in the research field. <xref ref-type="table" rid="tab5">Table 5</xref> lists the top 10 high-frequency keywords, cerebrotendinous xanthomatosis (411), chenodeoxycholic acid (152), cholesterol (91), mutation (82), bile acid (71) in the top five, and all of them had a centrality &#x003E; 0.1.</p>
<table-wrap position="float" id="tab5">
<label>Table 5</label>
<caption>
<p>Top 10 keywords with the highest frequency of occurrence.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Rank</th>
<th align="left" valign="top">Keyword</th>
<th align="center" valign="top">Occurrences</th>
<th align="center" valign="top">Centrality</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="middle">1</td>
<td align="left" valign="middle">cerebrotendinous xanthomatosis</td>
<td align="center" valign="middle">411</td>
<td align="char" valign="middle" char=".">0.35</td>
</tr>
<tr>
<td align="left" valign="middle">2</td>
<td align="left" valign="middle">chenodeoxycholic acid</td>
<td align="center" valign="middle">152</td>
<td align="char" valign="middle" char=".">0.16</td>
</tr>
<tr>
<td align="left" valign="middle">3</td>
<td align="left" valign="middle">mutation</td>
<td align="center" valign="middle">91</td>
<td align="char" valign="middle" char=".">0.14</td>
</tr>
<tr>
<td align="left" valign="middle">4</td>
<td align="left" valign="middle">cholesterol</td>
<td align="center" valign="middle">82</td>
<td align="char" valign="middle" char=".">0.19</td>
</tr>
<tr>
<td align="left" valign="middle">5</td>
<td align="left" valign="middle">bile acid</td>
<td align="center" valign="middle">71</td>
<td align="char" valign="middle" char=".">0.18</td>
</tr>
<tr>
<td align="left" valign="middle">6</td>
<td align="left" valign="middle">disease</td>
<td align="center" valign="middle">51</td>
<td align="char" valign="middle" char=".">0.12</td>
</tr>
<tr>
<td align="left" valign="middle">7</td>
<td align="left" valign="middle">diagnosis</td>
<td align="center" valign="middle">49</td>
<td align="char" valign="middle" char=".">0.03</td>
</tr>
<tr>
<td align="left" valign="middle">8</td>
<td align="left" valign="middle">metabolism</td>
<td align="center" valign="middle">48</td>
<td align="char" valign="middle" char=".">0.06</td>
</tr>
<tr>
<td align="left" valign="middle">9</td>
<td align="left" valign="middle">sterol 27 hydroxylase</td>
<td align="center" valign="middle">46</td>
<td align="char" valign="middle" char=".">0.12</td>
</tr>
<tr>
<td align="left" valign="middle">10</td>
<td align="left" valign="middle">cholestanol</td>
<td align="center" valign="middle">45</td>
<td align="char" valign="middle" char=".">0.09</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>The analysis of keyword co-occurrence by VOSviewer showed that the keywords formed three clusters as shown in <xref ref-type="fig" rid="fig8">Figure 8A</xref>. The first cluster (red) mainly includes the diagnosis and treatment of CTX such as diagnosis disease follow-up therapy. The second cluster (green) mainly explores the pathogenesis of CTX such as cholesterol sterol 27-hydroxylase bile acid biosynthesis oxysterol. The third cluster (blue) mainly focused on the prognosis of CTX such as metabolism primary biliary-cirrhosis neonatal cholestasis liver-disease.</p>
<fig position="float" id="fig8">
<label>Figure 8</label>
<caption>
<p>The analysis of keywords and cited references. <bold>(A)</bold> Visualization of keywords. <bold>(B)</bold> The top 25 keywords with the strongest citation bursts. Nodes denote keywords, with node size reflecting co-occurrence frequency. Strength indicates the intensity of citation bursts, with red signifying the duration of burst emergence.</p>
</caption>
<graphic xlink:href="fneur-15-1371375-g008.tif"/>
</fig>
<p>Keywords were detected and analyzed for bursts using CiteSpace, <xref ref-type="fig" rid="fig8">Figure 8B</xref> shows the keywords in the top 25 of burst intensity. Diagnosis ranked first in burst intensity, followed by sterol 27 hydroxylase gene (7.88) and acid biosynthetic enzyme (7.25). 26 hydroxylation is a keyword that burst lasts for a long time. In recent years, the research hotspots for bursts have been diagnosis, disease, <italic>CYP27A1</italic> gene, inborn error metabolism and spectrum.</p>
<p>Over the past three decades research has greatly enhanced our understanding of CTX which can be outlined as follows: (1) Insight into the genetic landscape with the identification of several new and rare <italic>CYP27A1</italic> gene mutations contributing to the recognition of genetic variability in CTX (<xref ref-type="bibr" rid="ref19">19</xref>). (2) Detailed exploration of clinical symptoms where early detection and intervention have been shown to notably improve patient prognoses (<xref ref-type="bibr" rid="ref20">20</xref>, <xref ref-type="bibr" rid="ref21">21</xref>). (3) Advancements in diagnostic approaches with the rise in levels of 7alpha-hydroxy-4-cholesten-3-one and cholesterol precursors confirmed as significant biomarkers for CTX (<xref ref-type="bibr" rid="ref22">22</xref>). The broad use of imaging techniques such as MRI to detect the deposition of cholesterol and lipids in the brain (<xref ref-type="bibr" rid="ref23">23</xref>).</p>
</sec>
</sec>
<sec sec-type="discussion" id="sec15">
<label>4</label>
<title>Discussion</title>
<sec id="sec16">
<label>4.1</label>
<title>General information</title>
<p>From the curve fitting results in <xref ref-type="fig" rid="fig1">Figure 1</xref>, it can be seen that although the annual number of papers published fluctuates greatly, the cumulative number of papers shows a rapid growth trend as a whole. From each viewpoint of time, the number of published articles was unstable from 1999 to 2005, and dropped sharply to 8 in 2005, which indicated that the study of CTX was still in its infancy and did not attract the attention of scholars at that time. However, the curve has shown an overall upward trend since 2005 and reached a peak in 2021.</p>
<p>From the perspective of countries and institutions, the United States is the main contributor, and it is the country with the largest number of publications and the highest centrality. Although the number of German publications ranks 7, its centrality was 2nd, which indicated that its academic status and influence in the field of CTX are better than others. As for China, although it has 44 publications, its centrality was 0, which showed that China has little cooperation with other countries and needs to strengthen effective academic exchanges. Most of the top 5 institutions were located in North America and Europe, and Oregon Health &#x0026; Science University and Helmholtz Association were the top 2 centrality institutions, which showed that they are playing an important role in the field of CTX research and their international academic influence has been further strengthen.</p>
<p>Regarding author productivity, Bj&#x00F6;rkhem I. has published the most works in the last three decades, with Salen G. and Federico A. ranking second and third, respectively. In addition, Bj&#x00F6;rkhem I. stands as the author with the highest number of citations in publications, achieving considerable progress in the biochemistry of CTX. He found that sterol 27-hydroxylase is a key enzyme in the conversion of cholesterol to 27-oxygenated steroids, and that loss of sterol 27-hydroxylase induces CTX and is associated with an early risk of atherosclerosis (<xref ref-type="bibr" rid="ref24 ref25 ref26">24&#x2013;26</xref>). Salen G. and Berginer V. M. have made groundbreaking contributions to the identification and treatment of CTX. Salen and his team had confirmed that CDCA is the most effective treatment. There is a significant increase in the risk of osteoporosis and fracture in patients with CTX (<xref ref-type="bibr" rid="ref27">27</xref>, <xref ref-type="bibr" rid="ref28">28</xref>). Berginer and his team contributed to the accurate diagnosis of CTX by investigating the genetic architecture and traits of prevalent CTX mutation alleles among Moroccan Jews (<xref ref-type="bibr" rid="ref29">29</xref>). Among the top 25 cited authors, Nie S. K. and his team indicate that increased cholesterol levels in CTX patients may lead to degeneration in the nigrostriatal dopaminergic pathway, potentially exacerbating the progression of Parkinson&#x2019;s syndrome (<xref ref-type="bibr" rid="ref30">30</xref>). Oftebro H. found that the metabolic defect in CTX is due to a complete absence of mitochondrial C27-steroid 26-hydroxylase (<xref ref-type="bibr" rid="ref6">6</xref>).</p>
<p>With regard to journals, it can be seen from <xref ref-type="table" rid="tab4">Table 4</xref> that Journal of Lipid Research is the journal with the most output and citations, which shows that the journal has made great contributions in the field of CTX research. The journals listed in <xref ref-type="table" rid="tab4">Table 4</xref> belong to the Q1 or Q2, which indicated that these journals have a high academic status in CTX research and are supported by the majority of scholars.</p>
</sec>
<sec id="sec17">
<label>4.2</label>
<title>The hotspots and frontiers</title>
<p>Based on keyword co-occurrence, clustering, burst detection analysis and burst detection analysis of references, we have established the research hotspots of CTX: pathogenesis, diagnosis and treatment.</p>
<sec id="sec18">
<label>4.2.1</label>
<title>Pathogenesis</title>
<p>CTX is caused by a mutation in the <italic>CYP27A1</italic> gene that encodes sterol 27-hydroxylase, a key enzyme in the bile acid biosynthesis pathway (<xref ref-type="bibr" rid="ref31">31</xref>, <xref ref-type="bibr" rid="ref32">32</xref>). The classical pathway is initiated by cholesterol 7 &#x03B1;-hydroxylation and catalyzed by rate-limiting enzyme cholesterol 7 &#x03B1;-hydroxylase. The alternative pathway is initiated by sterol 27-hydroxylase catalyzed 27-hydroxylation of cholesterol (<xref ref-type="bibr" rid="ref33">33</xref>). The decrease of sterol 27-hydroxylase activity leads to the impairment of bile acid synthesis in classical and alternative pathways, resulting in the decrease of bile acid (especially CDCA) production and the decrease of bile acid production to a lesser extent. The loss of negative feedback of CDCA on cholesterol 7 &#x03B1;-hydroxylase accelerates these metabolic abnormalities, resulting in an increase in the level of bile acid intermediate 7alpha-hydroxy-4-cholesten-3-one, a precursor of cholesterol and bile alcohol (<xref ref-type="bibr" rid="ref34">34</xref>).</p>
</sec>
<sec id="sec19">
<label>4.2.2</label>
<title>Diagnosis</title>
<p>The diagnosis of CTX usually involves clinical observations, biochemical assessments, and genetic evaluations, with neuroimaging acting as a supportive diagnostic criterion. The most notable neuroradiological features are the presence of signal hyperintensities observed in T2-weighted and/or FLAIR imaging, particularly in the dentate nuclei and the surrounding cerebellar white matter (<xref ref-type="bibr" rid="ref35">35</xref>, <xref ref-type="bibr" rid="ref36">36</xref>). Early diagnosis of CTX is crucial, as initiating treatment in the early stages can significantly improve symptoms and slow the deterioration of neurological functions (<xref ref-type="bibr" rid="ref37">37</xref>). However, delayed diagnosis of CTX is common. Koyama et al. (<xref ref-type="bibr" rid="ref33">33</xref>) proposed a new diagnostic criterion, which can be diagnosed as CTX only when there is at least one clinical symptom associated with CTX and the serum cholestanol is elevated (&#x2265;4.5&#x2009;&#x03BC;g/mL, mean&#x2009;&#x00B1;&#x2009;SD: 2.35&#x2009;&#x00B1;&#x2009;0.73&#x2009;&#x03BC;g/mL). Genetic testing is essential, as known mutations in the <italic>CYP7A1</italic> gene have been identified as triggers for CTX (<xref ref-type="bibr" rid="ref38">38</xref>, <xref ref-type="bibr" rid="ref39">39</xref>).</p>
</sec>
<sec id="sec20">
<label>4.2.3</label>
<title>Treatment</title>
<p>The most effective treatment is chenodeoxycholic acid therapy (<xref ref-type="bibr" rid="ref2">2</xref>, <xref ref-type="bibr" rid="ref40">40</xref>). It operates by suppressing the synthesis of bile acids via a negative feedback pathway, effectively hindering the buildup of cholestanol (<xref ref-type="bibr" rid="ref41">41</xref>). Studies have demonstrated that CDCA is not only effective in the long-term treatment of CTX but also maintains a favorable safety profile (<xref ref-type="bibr" rid="ref42">42</xref>).</p>
</sec>
</sec>
<sec id="sec21">
<label>4.3</label>
<title>Limitation</title>
<p>There are some limitations to our study. To begin with, we exclusively utilized the WoSCC database for our search. Moreover, we only included publications that were in English-language publications and categorized them as articles or reviews. Lastly, the basic functionalities of CiteSpace and VOSviewer were constrained, enabling us to analyze citation data for a maximum duration of 30&#x2009;years.</p>
</sec>
</sec>
<sec sec-type="conclusions" id="sec22">
<label>5</label>
<title>Conclusion</title>
<p>CTX literature from 1993 to 2023 were summarized and visually analyzed. The results showed that although the number of articles published every year fluctuates greatly, the depth and breadth of the research are constantly expanding. Although more and more countries, institutions and scholars have focused on CTX, the pathogenesis, diagnosis and treatment of CTX are still difficult problems to be solved urgently. Therefore, more efficient and accurate early diagnosis and treatment will be the focus of future research.</p>
</sec>
<sec sec-type="data-availability" id="sec23">
<title>Data availability statement</title>
<p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p>
</sec>
<sec sec-type="ethics-statement" id="sec24">
<title>Ethics statement</title>
<p>Ethical review and approval was not required for this study in accordance with the local legislation and institutional requirements.</p>
</sec>
<sec sec-type="author-contributions" id="sec25">
<title>Author contributions</title>
<p>FL: Writing &#x2013; original draft, Writing &#x2013; review &#x0026; editing. YD: Data curation, Visualization, Writing &#x2013; review &#x0026; editing. SZ: Software, Writing &#x2013; review &#x0026; editing. JD: Supervision, Writing &#x2013; review &#x0026; editing. BY: Conceptualization, Writing &#x2013; review &#x0026; editing.</p>
</sec>
</body>
<back>
<sec sec-type="funding-information" id="sec26">
<title>Funding</title>
<p>The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.</p>
</sec>
<ack>
<p>The authors would like to express our great appreciation to editor and reviewers.</p>
</ack>
<sec sec-type="COI-statement" id="sec27">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="sec28">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec sec-type="supplementary-material" id="sec29">
<title>Supplementary material</title>
<p>The Supplementary material for this article can be found online at: <ext-link xlink:href="https://www.frontiersin.org/articles/10.3389/fneur.2024.1371375/full#supplementary-material" ext-link-type="uri">https://www.frontiersin.org/articles/10.3389/fneur.2024.1371375/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="Table_1.XLSX" id="SM1" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<fn-group>
<fn id="fn0001">
<p><sup>1</sup><ext-link xlink:href="https://bibliometric.com/" ext-link-type="uri">https://bibliometric.com/</ext-link></p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="ref1"><label>1.</label> <citation citation-type="book"><person-group person-group-type="author"><name><surname>Van Bogaert</surname> <given-names>L</given-names></name> <name><surname>van Bogaert</surname> <given-names>L</given-names></name> <name><surname>Scherer</surname> <given-names>HJ</given-names></name> <name><surname>Epstein</surname> <given-names>E</given-names></name></person-group>. <source>Une forme c&#x00E9;r&#x00E9;brale de cholest&#x00E9;ri-nose g&#x00E9;n&#x00E9;ralis&#x00E9;e</source>. <publisher-loc>Paris</publisher-loc>: <publisher-name>Masson</publisher-name> (<year>1937</year>).</citation></ref>
<ref id="ref2"><label>2.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>DeBarber</surname> <given-names>AE</given-names></name> <name><surname>Duell</surname> <given-names>PB</given-names></name></person-group>. <article-title>Update on cerebrotendinous xanthomatosis</article-title>. <source>Curr Opin Lipidol</source>. (<year>2021</year>) <volume>32</volume>:<fpage>123</fpage>&#x2013;<lpage>31</lpage>. doi: <pub-id pub-id-type="doi">10.1097/MOL.0000000000000740</pub-id>, PMID: <pub-id pub-id-type="pmid">33630770</pub-id></citation></ref>
<ref id="ref3"><label>3.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Salen</surname> <given-names>G</given-names></name> <name><surname>Steiner</surname> <given-names>RD</given-names></name></person-group>. <article-title>Epidemiology, diagnosis, and treatment of cerebrotendinous xanthomatosis (CTX)</article-title>. <source>J Inherit Metab Dis</source>. (<year>2017</year>) <volume>40</volume>:<fpage>771</fpage>&#x2013;<lpage>81</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s10545-017-0093-8</pub-id>, PMID: <pub-id pub-id-type="pmid">28980151</pub-id></citation></ref>
<ref id="ref4"><label>4.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Menkes</surname> <given-names>JH</given-names></name> <name><surname>Schimschock</surname> <given-names>JR</given-names></name> <name><surname>Swanson</surname> <given-names>PD</given-names></name></person-group>. <article-title>Cerebrotendinous xanthomatosis. The storage of cholestanol within the nervous system</article-title>. <source>Arch Neurol</source>. (<year>1968</year>) <volume>19</volume>:<fpage>47</fpage>&#x2013;<lpage>53</lpage>. doi: <pub-id pub-id-type="doi">10.1001/archneur.1968.00480010065004</pub-id>, PMID: <pub-id pub-id-type="pmid">5676919</pub-id></citation></ref>
<ref id="ref5"><label>5.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Salen</surname> <given-names>G</given-names></name></person-group>. <article-title>Cholestanol deposition in cerebrotendinous xanthomatosis. A possible mechanism</article-title>. <source>Ann Intern Med</source>. (<year>1971</year>) <volume>75</volume>:<fpage>843</fpage>&#x2013;<lpage>51</lpage>. doi: <pub-id pub-id-type="doi">10.7326/0003-4819-75-6-843</pub-id></citation></ref>
<ref id="ref6"><label>6.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Oftebro</surname> <given-names>H</given-names></name> <name><surname>Bj&#x00F6;rkhem</surname> <given-names>I</given-names></name> <name><surname>St&#x00F8;rmer</surname> <given-names>FC</given-names></name> <name><surname>Pedersen</surname> <given-names>JI</given-names></name></person-group>. <article-title>Cerebrotendinous xanthomatosis: defective liver mitochondrial hydroxylation of chenodeoxycholic acid precursors</article-title>. <source>J Lipid Res</source>. (<year>1981</year>) <volume>22</volume>:<fpage>632</fpage>&#x2013;<lpage>40</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0022-2275(20)37373-9</pub-id>, PMID: <pub-id pub-id-type="pmid">6792308</pub-id></citation></ref>
<ref id="ref7"><label>7.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cali</surname> <given-names>JJ</given-names></name> <name><surname>Hsieh</surname> <given-names>CL</given-names></name> <name><surname>Francke</surname> <given-names>U</given-names></name> <name><surname>Russell</surname> <given-names>DW</given-names></name></person-group>. <article-title>Mutations in the bile acid biosynthetic enzyme sterol 27-hydroxylase underlie cerebrotendinous xanthomatosis</article-title>. <source>J Biol Chem</source>. (<year>1991</year>) <volume>266</volume>:<fpage>7779</fpage>&#x2013;<lpage>83</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0021-9258(20)89518-0</pub-id>, PMID: <pub-id pub-id-type="pmid">2019602</pub-id></citation></ref>
<ref id="ref8"><label>8.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pramparo</surname> <given-names>T</given-names></name> <name><surname>Steiner</surname> <given-names>RD</given-names></name> <name><surname>Rodems</surname> <given-names>S</given-names></name> <name><surname>Jenkinson</surname> <given-names>C</given-names></name></person-group>. <article-title>Allelic prevalence and geographic distribution of cerebrotendinous xanthomatosis</article-title>. <source>Orphanet J Rare Dis</source>. (<year>2023</year>) <volume>18</volume>:<fpage>13</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s13023-022-02578-1</pub-id>, PMID: <pub-id pub-id-type="pmid">36650582</pub-id></citation></ref>
<ref id="ref9"><label>9.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gong</surname> <given-names>J</given-names></name> <name><surname>Setchell</surname> <given-names>KDR</given-names></name> <name><surname>Zhao</surname> <given-names>J</given-names></name> <name><surname>Zhang</surname> <given-names>W</given-names></name> <name><surname>Wolfe</surname> <given-names>B</given-names></name> <name><surname>Lu</surname> <given-names>Y</given-names></name> <etal/></person-group>. <article-title>Severe neonatal cholestasis in cerebrotendinous xanthomatosis: genetics, immunostaining, mass spectrometry</article-title>. <source>J Pediatr Gastroenterol Nutr</source>. (<year>2017</year>) <volume>65</volume>:<fpage>561</fpage>&#x2013;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.1097/MPG.0000000000001730</pub-id>, PMID: <pub-id pub-id-type="pmid">28937538</pub-id></citation></ref>
<ref id="ref10"><label>10.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stelten</surname> <given-names>BML</given-names></name> <name><surname>Huidekoper</surname> <given-names>HH</given-names></name> <name><surname>van de Warrenburg</surname> <given-names>BPC</given-names></name> <name><surname>Brilstra</surname> <given-names>EH</given-names></name> <name><surname>Hollak</surname> <given-names>CEM</given-names></name> <name><surname>Haak</surname> <given-names>HR</given-names></name> <etal/></person-group>. <article-title>Long-term treatment effect in cerebrotendinous xanthomatosis depends on age at treatment start</article-title>. <source>Neurology</source>. (<year>2019</year>) <volume>92</volume>:<fpage>e83</fpage>&#x2013;<lpage>95</lpage>. doi: <pub-id pub-id-type="doi">10.1212/WNL.0000000000006731</pub-id>, PMID: <pub-id pub-id-type="pmid">30530799</pub-id></citation></ref>
<ref id="ref11"><label>11.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ribeiro</surname> <given-names>RM</given-names></name> <name><surname>Vasconcelos</surname> <given-names>SC</given-names></name> <name><surname>Lima</surname> <given-names>PLGSB</given-names></name> <name><surname>Coelho</surname> <given-names>EF</given-names></name> <name><surname>AMN</surname> <given-names>O</given-names></name> <name><surname>EABM</surname> <given-names>G</given-names></name> <etal/></person-group>. <article-title>Pathophysiology and treatment of lipid abnormalities in cerebrotendinous xanthomatosis: an integrative review</article-title>. <source>Brain Sci</source>. (<year>2023</year>) <volume>13</volume>:<fpage>979</fpage>. doi: <pub-id pub-id-type="doi">10.3390/brainsci13070979</pub-id>, PMID: <pub-id pub-id-type="pmid">37508912</pub-id></citation></ref>
<ref id="ref12"><label>12.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>C</given-names></name></person-group>. <article-title>CiteSpace II: detecting and visualizing emerging trends and transient patterns in scientific literature</article-title>. <source>J Am Soc Inf Sci Technol</source>. (<year>2006</year>) <volume>57</volume>:<fpage>359</fpage>&#x2013;<lpage>77</lpage>. doi: <pub-id pub-id-type="doi">10.1002/asi.20317</pub-id></citation></ref>
<ref id="ref13"><label>13.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>van Eck</surname> <given-names>NJ</given-names></name> <name><surname>Waltman</surname> <given-names>L</given-names></name></person-group>. <article-title>Software survey: VOSviewer, a computer program for bibliometric mapping</article-title>. <source>Scientometrics</source>. (<year>2010</year>) <volume>84</volume>:<fpage>523</fpage>&#x2013;<lpage>38</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s11192-009-0146-3</pub-id>, PMID: <pub-id pub-id-type="pmid">20585380</pub-id></citation></ref>
<ref id="ref14"><label>14.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname> <given-names>F</given-names></name> <name><surname>Li</surname> <given-names>Y</given-names></name> <name><surname>Zhang</surname> <given-names>Y</given-names></name> <name><surname>Song</surname> <given-names>Y</given-names></name> <name><surname>Diao</surname> <given-names>J</given-names></name></person-group>. <article-title>Bibliometric analysis of IgA vasculitis nephritis in children from 2000 to 2022</article-title>. <source>Front Public Health</source>. (<year>2022</year>) <volume>10</volume>:<fpage>1020231</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fpubh.2022.1020231</pub-id>, PMID: <pub-id pub-id-type="pmid">36276396</pub-id></citation></ref>
<ref id="ref15"><label>15.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bakkalbasi</surname> <given-names>N</given-names></name> <name><surname>Bauer</surname> <given-names>K</given-names></name> <name><surname>Glover</surname> <given-names>J</given-names></name> <name><surname>Wang</surname> <given-names>L</given-names></name></person-group>. <article-title>Three options for citation tracking: Google Scholar, Scopus and Web of Science</article-title>. <source>Biomed Digit Libr</source>. (<year>2006</year>) <volume>3</volume>:<fpage>7</fpage>. doi: <pub-id pub-id-type="doi">10.1186/1742-5581-3-7</pub-id>, PMID: <pub-id pub-id-type="pmid">16805916</pub-id></citation></ref>
<ref id="ref16"><label>16.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Falagas</surname> <given-names>ME</given-names></name> <name><surname>Pitsouni</surname> <given-names>EI</given-names></name> <name><surname>Malietzis</surname> <given-names>GA</given-names></name> <name><surname>Pappas</surname> <given-names>G</given-names></name></person-group>. <article-title>Comparison of PubMed, Scopus, Web of Science, and Google Scholar: strengths and weaknesses</article-title>. <source>FASEB J</source>. (<year>2008</year>) <volume>22</volume>:<fpage>338</fpage>&#x2013;<lpage>42</lpage>. doi: <pub-id pub-id-type="doi">10.1096/fj.07-9492LSF</pub-id></citation></ref>
<ref id="ref17"><label>17.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>AlRyalat</surname> <given-names>SAS</given-names></name> <name><surname>Malkawi</surname> <given-names>LW</given-names></name> <name><surname>Momani</surname> <given-names>SM</given-names></name></person-group>. <article-title>Comparing bibliometric analysis using PubMed, Scopus, and Web of Science Databases</article-title>. <source>J Vis Exp</source>. (<year>2019</year>). e58494. doi: <pub-id pub-id-type="doi">10.3791/58494</pub-id></citation></ref>
<ref id="ref18"><label>18.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname> <given-names>J</given-names></name> <name><surname>Ling</surname> <given-names>F</given-names></name> <name><surname>Huang</surname> <given-names>P</given-names></name> <name><surname>Chen</surname> <given-names>M</given-names></name> <name><surname>Song</surname> <given-names>M</given-names></name> <name><surname>Lu</surname> <given-names>K</given-names></name> <etal/></person-group>. <article-title>The development of GABAergic network in depression in recent 17 years: a visual analysis based on CiteSpace and VOSviewer</article-title>. <source>Front Psychiatry</source>. (<year>2022</year>) <volume>13</volume>:<fpage>874137</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fpsyt.2022.874137</pub-id>, PMID: <pub-id pub-id-type="pmid">35664493</pub-id></citation></ref>
<ref id="ref19"><label>19.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gallus</surname> <given-names>GN</given-names></name> <name><surname>Dotti</surname> <given-names>MT</given-names></name> <name><surname>Federico</surname> <given-names>A</given-names></name></person-group>. <article-title>Clinical and molecular diagnosis of cerebrotendinous xanthomatosis with a review of the mutations in the CYP27A1 gene</article-title>. <source>Neurol Sci</source>. (<year>2006</year>) <volume>27</volume>:<fpage>143</fpage>&#x2013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s10072-006-0618-7</pub-id>, PMID: <pub-id pub-id-type="pmid">16816916</pub-id></citation></ref>
<ref id="ref20"><label>20.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mignarri</surname> <given-names>A</given-names></name> <name><surname>Gallus</surname> <given-names>GN</given-names></name> <name><surname>Dotti</surname> <given-names>MT</given-names></name> <name><surname>Federico</surname> <given-names>A</given-names></name></person-group>. <article-title>A suspicion index for early diagnosis and treatment of cerebrotendinous xanthomatosis</article-title>. <source>J Inherit Metab Dis</source>. (<year>2014</year>) <volume>37</volume>:<fpage>421</fpage>&#x2013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s10545-013-9674-3</pub-id>, PMID: <pub-id pub-id-type="pmid">24442603</pub-id></citation></ref>
<ref id="ref21"><label>21.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Degos</surname> <given-names>B</given-names></name> <name><surname>Nadjar</surname> <given-names>Y</given-names></name> <name><surname>Amador</surname> <given-names>MDM</given-names></name> <name><surname>Lamari</surname> <given-names>F</given-names></name> <name><surname>Sedel</surname> <given-names>F</given-names></name> <name><surname>Roze</surname> <given-names>E</given-names></name> <etal/></person-group>. <article-title>Natural history of cerebrotendinous xanthomatosis: a paediatric disease diagnosed in adulthood</article-title>. <source>Orphanet J Rare Dis</source>. (<year>2016</year>) <volume>11</volume>:<fpage>41</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s13023-016-0419-x</pub-id>, PMID: <pub-id pub-id-type="pmid">27084087</pub-id></citation></ref>
<ref id="ref22"><label>22.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>L&#x00FC;tjohann</surname> <given-names>D</given-names></name> <name><surname>Stellaard</surname> <given-names>F</given-names></name> <name><surname>Bj&#x00F6;rkhem</surname> <given-names>I</given-names></name></person-group>. <article-title>Levels of 7alpha-hydroxycholesterol and/or 7alpha-hydroxy-4-cholest-3-one are the optimal biochemical markers for the evaluation of treatment of cerebrotendinous xanthomatosis</article-title>. <source>J Neurol</source>. (<year>2020</year>) <volume>267</volume>:<fpage>572</fpage>&#x2013;<lpage>3</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00415-019-09650-0</pub-id>, PMID: <pub-id pub-id-type="pmid">31781930</pub-id></citation></ref>
<ref id="ref23"><label>23.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>G&#x00F3;mez-Huertas</surname> <given-names>M</given-names></name> <name><surname>Mart&#x00ED;nez-Barbero</surname> <given-names>JP</given-names></name> <name><surname>P&#x00E9;rez-Rosillo</surname> <given-names>M&#x00C1;</given-names></name></person-group>. <article-title>Utilidad de la resonancia magn&#x00E9;tica cerebral en el diagn&#x00F3;stico de la xantomatosis cerebrotendinosa</article-title>. <source>Med Clin</source>. (<year>2019</year>) <volume>152</volume>:<fpage>41</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.medcli.2017.12.022</pub-id>, PMID: <pub-id pub-id-type="pmid">29599059</pub-id></citation></ref>
<ref id="ref24"><label>24.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bj&#x00F6;rkhem</surname> <given-names>I</given-names></name> <name><surname>Andersson</surname> <given-names>O</given-names></name> <name><surname>Diczfalusy</surname> <given-names>U</given-names></name> <name><surname>Sevastik</surname> <given-names>B</given-names></name> <name><surname>Xiu</surname> <given-names>RJ</given-names></name> <name><surname>Duan</surname> <given-names>C</given-names></name> <etal/></person-group>. <article-title>Atherosclerosis and sterol 27-hydroxylase: evidence for a role of this enzyme in elimination of cholesterol from human macrophages</article-title>. <source>Proc Natl Acad Sci USA</source>. (<year>1994</year>) <volume>91</volume>:<fpage>8592</fpage>&#x2013;<lpage>6</lpage>. doi: <pub-id pub-id-type="doi">10.1073/pnas.91.18.8592</pub-id>, PMID: <pub-id pub-id-type="pmid">8078928</pub-id></citation></ref>
<ref id="ref25"><label>25.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Babiker</surname> <given-names>A</given-names></name> <name><surname>Andersson</surname> <given-names>O</given-names></name> <name><surname>Lund</surname> <given-names>E</given-names></name> <name><surname>Xiu</surname> <given-names>RJ</given-names></name> <name><surname>Deeb</surname> <given-names>S</given-names></name> <name><surname>Reshef</surname> <given-names>A</given-names></name> <etal/></person-group>. <article-title>Elimination of cholesterol in macrophages and endothelial cells by the sterol 27-hydroxylase mechanism. Comparison with high density lipoprotein-mediated reverse cholesterol transport</article-title>. <source>J Biol Chem</source>. (<year>1997</year>) <volume>272</volume>:<fpage>26253</fpage>&#x2013;<lpage>61</lpage>. doi: <pub-id pub-id-type="doi">10.1074/jbc.272.42.26253</pub-id>, PMID: <pub-id pub-id-type="pmid">9334194</pub-id></citation></ref>
<ref id="ref26"><label>26.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rosen</surname> <given-names>H</given-names></name> <name><surname>Reshef</surname> <given-names>A</given-names></name> <name><surname>Maeda</surname> <given-names>N</given-names></name> <name><surname>Lippoldt</surname> <given-names>A</given-names></name> <name><surname>Shpizen</surname> <given-names>S</given-names></name> <name><surname>Triger</surname> <given-names>L</given-names></name> <etal/></person-group>. <article-title>Markedly reduced bile acid synthesis but maintained levels of cholesterol and vitamin D metabolites in mice with disrupted sterol 27-hydroxylase gene</article-title>. <source>J Biol Chem</source>. (<year>1998</year>) <volume>273</volume>:<fpage>14805</fpage>&#x2013;<lpage>12</lpage>. doi: <pub-id pub-id-type="doi">10.1074/jbc.273.24.14805</pub-id>, PMID: <pub-id pub-id-type="pmid">9614081</pub-id></citation></ref>
<ref id="ref27"><label>27.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moghadasian</surname> <given-names>MH</given-names></name> <name><surname>Salen</surname> <given-names>G</given-names></name> <name><surname>Frohlich</surname> <given-names>JJ</given-names></name> <name><surname>Scudamore</surname> <given-names>CH</given-names></name></person-group>. <article-title>Cerebrotendinous xanthomatosis: a rare disease with diverse manifestations</article-title>. <source>Arch Neurol</source>. (<year>2002</year>) <volume>59</volume>:<fpage>527</fpage>&#x2013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1001/archneur.59.4.527</pub-id></citation></ref>
<ref id="ref28"><label>28.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Berginer</surname> <given-names>VM</given-names></name> <name><surname>Shany</surname> <given-names>S</given-names></name> <name><surname>Alkalay</surname> <given-names>D</given-names></name> <name><surname>Berginer</surname> <given-names>J</given-names></name> <name><surname>Dekel</surname> <given-names>S</given-names></name> <name><surname>Salen</surname> <given-names>G</given-names></name> <etal/></person-group>. <article-title>Osteoporosis and increased bone fractures in cerebrotendinous xanthomatosis</article-title>. <source>Metab Clin Exp</source>. (<year>1993</year>) <volume>42</volume>:<fpage>69</fpage>&#x2013;<lpage>74</lpage>. doi: <pub-id pub-id-type="doi">10.1016/0026-0495(93)90174-M</pub-id>, PMID: <pub-id pub-id-type="pmid">8446051</pub-id></citation></ref>
<ref id="ref29"><label>29.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Leitersdorf</surname> <given-names>E</given-names></name> <name><surname>Reshef</surname> <given-names>A</given-names></name> <name><surname>Meiner</surname> <given-names>V</given-names></name> <name><surname>Levitzki</surname> <given-names>R</given-names></name> <name><surname>Schwartz</surname> <given-names>SP</given-names></name> <name><surname>Dann</surname> <given-names>EJ</given-names></name> <etal/></person-group>. <article-title>Frameshift and splice-junction mutations in the sterol 27-hydroxylase gene cause cerebrotendinous xanthomatosis in Jews or Moroccan origin</article-title>. <source>J Clin Invest</source>. (<year>1993</year>) <volume>91</volume>:<fpage>2488</fpage>&#x2013;<lpage>96</lpage>. doi: <pub-id pub-id-type="doi">10.1172/JCI116484</pub-id>, PMID: <pub-id pub-id-type="pmid">8514861</pub-id></citation></ref>
<ref id="ref30"><label>30.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname> <given-names>T</given-names></name> <name><surname>Nie</surname> <given-names>S</given-names></name> <name><surname>Bu</surname> <given-names>L</given-names></name> <name><surname>Liu</surname> <given-names>M</given-names></name> <name><surname>He</surname> <given-names>J</given-names></name> <name><surname>Niu</surname> <given-names>X</given-names></name> <etal/></person-group>. <article-title>Cholestanol accelerates &#x03B1;-synuclein aggregation and spreading by activating asparagine endopeptidase</article-title>. <source>JCI Insight</source>. (<year>2023</year>) <volume>8</volume>:<fpage>e165841</fpage>. doi: <pub-id pub-id-type="doi">10.1172/jci.insight.165841</pub-id>, PMID: <pub-id pub-id-type="pmid">37937646</pub-id></citation></ref>
<ref id="ref31"><label>31.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>S</given-names></name> <name><surname>Li</surname> <given-names>W</given-names></name> <name><surname>Zheng</surname> <given-names>R</given-names></name> <name><surname>Zhao</surname> <given-names>B</given-names></name> <name><surname>Zhang</surname> <given-names>Y</given-names></name> <name><surname>Zhao</surname> <given-names>D</given-names></name> <etal/></person-group>. <article-title>Cerebrotendinous xanthomatosis with peripheral neuropathy: a clinical and neurophysiological study in Chinese population</article-title>. <source>Ann Transl Med</source>. (<year>2020</year>) <volume>8</volume>:<fpage>1372</fpage>. doi: <pub-id pub-id-type="doi">10.21037/atm-20-2746</pub-id>, PMID: <pub-id pub-id-type="pmid">33313117</pub-id></citation></ref>
<ref id="ref32"><label>32.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xiao</surname> <given-names>Z</given-names></name> <name><surname>Li</surname> <given-names>L</given-names></name> <name><surname>Liao</surname> <given-names>W</given-names></name> <name><surname>Li</surname> <given-names>Z</given-names></name></person-group>. <article-title>Cerebrotendinous xanthomatosis: a case report</article-title>. <source>Asian J Surg</source>. (<year>2022</year>) <volume>45</volume>:<fpage>786</fpage>&#x2013;<lpage>7</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.asjsur.2021.11.063</pub-id></citation></ref>
<ref id="ref33"><label>33.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Koyama</surname> <given-names>S</given-names></name> <name><surname>Sekijima</surname> <given-names>Y</given-names></name> <name><surname>Ogura</surname> <given-names>M</given-names></name> <name><surname>Hori</surname> <given-names>M</given-names></name> <name><surname>Matsuki</surname> <given-names>K</given-names></name> <name><surname>Miida</surname> <given-names>T</given-names></name> <etal/></person-group>. <article-title>Cerebrotendinous xanthomatosis: molecular pathogenesis, clinical spectrum, diagnosis, and disease-modifying treatments</article-title>. <source>J Atheroscler Thromb</source>. (<year>2021</year>) <volume>28</volume>:<fpage>905</fpage>&#x2013;<lpage>25</lpage>. doi: <pub-id pub-id-type="doi">10.5551/jat.RV17055</pub-id>, PMID: <pub-id pub-id-type="pmid">33967188</pub-id></citation></ref>
<ref id="ref34"><label>34.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nie</surname> <given-names>S</given-names></name> <name><surname>Chen</surname> <given-names>G</given-names></name> <name><surname>Cao</surname> <given-names>X</given-names></name> <name><surname>Zhang</surname> <given-names>Y</given-names></name></person-group>. <article-title>Cerebrotendinous xanthomatosis: a comprehensive review of pathogenesis, clinical manifestations, diagnosis, and management</article-title>. <source>Orphanet J Rare Dis</source>. (<year>2014</year>) <volume>9</volume>:<fpage>179</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s13023-014-0179-4</pub-id>, PMID: <pub-id pub-id-type="pmid">25424010</pub-id></citation></ref>
<ref id="ref35"><label>35.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>De Stefano</surname> <given-names>N</given-names></name> <name><surname>Dotti</surname> <given-names>MT</given-names></name> <name><surname>Mortilla</surname> <given-names>M</given-names></name> <name><surname>Federico</surname> <given-names>A</given-names></name></person-group>. <article-title>Magnetic resonance imaging and spectroscopic changes in brains of patients with cerebrotendinous xanthomatosis</article-title>. <source>Brain</source>. (<year>2001</year>) <volume>124</volume>:<fpage>121</fpage>&#x2013;<lpage>31</lpage>. doi: <pub-id pub-id-type="doi">10.1093/brain/124.1.121</pub-id></citation></ref>
<ref id="ref36"><label>36.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barkhof</surname> <given-names>F</given-names></name> <name><surname>Verrips</surname> <given-names>A</given-names></name> <name><surname>Wesseling</surname> <given-names>P</given-names></name> <name><surname>van der Knaap</surname> <given-names>MS</given-names></name> <name><surname>van Engelen</surname> <given-names>BGM</given-names></name> <name><surname>Gabre&#x00EB;ls</surname> <given-names>FJM</given-names></name> <etal/></person-group>. <article-title>Cerebrotendinous xanthomatosis: the spectrum of imaging findings and the correlation with neuropathologic findings</article-title>. <source>Radiology</source>. (<year>2000</year>) <volume>217</volume>:<fpage>869</fpage>&#x2013;<lpage>76</lpage>. doi: <pub-id pub-id-type="doi">10.1148/radiology.217.3.r00dc03869</pub-id>, PMID: <pub-id pub-id-type="pmid">11110956</pub-id></citation></ref>
<ref id="ref37"><label>37.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>K&#x0131;sa</surname> <given-names>PT</given-names></name> <name><surname>Yildirim</surname> <given-names>GK</given-names></name> <name><surname>Hismi</surname> <given-names>BO</given-names></name> <name><surname>Dorum</surname> <given-names>S</given-names></name> <name><surname>Kusbeci</surname> <given-names>OY</given-names></name> <name><surname>Topak</surname> <given-names>A</given-names></name> <etal/></person-group>. <article-title>Patients with cerebrotendinous xanthomatosis diagnosed with diverse multisystem involvement</article-title>. <source>Metab Brain Dis</source>. (<year>2021</year>) <volume>36</volume>:<fpage>1201</fpage>&#x2013;<lpage>11</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s11011-021-00714-7</pub-id></citation></ref>
<ref id="ref38"><label>38.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname> <given-names>J</given-names></name> <name><surname>Chen</surname> <given-names>G</given-names></name> <name><surname>Wu</surname> <given-names>J</given-names></name> <name><surname>Luan</surname> <given-names>X</given-names></name> <name><surname>Zhou</surname> <given-names>H</given-names></name> <name><surname>Liu</surname> <given-names>X</given-names></name> <etal/></person-group>. <article-title>c.1263+1G&#x003E;A is a latent hotspot for CYP27A1 mutations in Chinese patients with cerebrotendinous xanthomatosis</article-title>. <source>Front Genet</source>. (<year>2020</year>) <volume>11</volume>:<fpage>682</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fgene.2020.00682</pub-id>, PMID: <pub-id pub-id-type="pmid">32714376</pub-id></citation></ref>
<ref id="ref39"><label>39.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Badura Stronka</surname> <given-names>M</given-names></name> <name><surname>Hirschfeld</surname> <given-names>AS</given-names></name> <name><surname>Winczewska Wiktor</surname> <given-names>A</given-names></name> <name><surname>Budzy&#x0144;ska</surname> <given-names>E</given-names></name> <name><surname>Jakubiuk-Tomaszuk</surname> <given-names>A</given-names></name> <name><surname>Piontek</surname> <given-names>A</given-names></name> <etal/></person-group>. <article-title>First case series of polish patients with cerebrotendinous xanthomatosis and systematic review of cases from the 21st century</article-title>. <source>Clin Genet</source>. (<year>2022</year>) <volume>101</volume>:<fpage>190</fpage>&#x2013;<lpage>207</lpage>. doi: <pub-id pub-id-type="doi">10.1111/cge.14079</pub-id>, PMID: <pub-id pub-id-type="pmid">34689324</pub-id></citation></ref>
<ref id="ref40"><label>40.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bj&#x00F6;rkhem</surname> <given-names>I</given-names></name></person-group>. <article-title>Cerebrotendinous xanthomatosis</article-title>. <source>Curr Opin Lipidol</source>. (<year>2013</year>) <volume>24</volume>:<fpage>283</fpage>&#x2013;<lpage>7</lpage>. doi: <pub-id pub-id-type="doi">10.1097/MOL.0b013e328362df13</pub-id></citation></ref>
<ref id="ref41"><label>41.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Batta</surname> <given-names>AK</given-names></name> <name><surname>Shefer</surname> <given-names>S</given-names></name> <name><surname>Batta</surname> <given-names>M</given-names></name> <name><surname>Salen</surname> <given-names>G</given-names></name></person-group>. <article-title>Effect of chenodeoxycholic acid on biliary and urinary bile acids and bile alcohols in cerebrotendinous xanthomatosis; monitoring by high performance liquid chromatography</article-title>. <source>J Lipid Res</source>. (<year>1985</year>) <volume>26</volume>:<fpage>690</fpage>&#x2013;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0022-2275(20)34325-X</pub-id>, PMID: <pub-id pub-id-type="pmid">4031647</pub-id></citation></ref>
<ref id="ref42"><label>42.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Verrips</surname> <given-names>A</given-names></name> <name><surname>Dotti</surname> <given-names>MT</given-names></name> <name><surname>Mignarri</surname> <given-names>A</given-names></name> <name><surname>Stelten</surname> <given-names>BML</given-names></name> <name><surname>Verma</surname> <given-names>S</given-names></name> <name><surname>Federico</surname> <given-names>A</given-names></name></person-group>. <article-title>The safety and effectiveness of chenodeoxycholic acid treatment in patients with cerebrotendinous xanthomatosis: two retrospective cohort studies</article-title>. <source>Neurol Sci</source>. (<year>2020</year>) <volume>41</volume>:<fpage>943</fpage>&#x2013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s10072-019-04169-8</pub-id>, PMID: <pub-id pub-id-type="pmid">31863326</pub-id></citation></ref>
</ref-list>
</back>
</article>